Brief: HLS Therapeutics Announces CFO Departure
18/12/2023 11:33
Dec 18 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES CFO DEPARTURE
* HLS THERAPEUTICS INC: JOHN HANNA APPOINTED INTERIM CFO TO
REPLACE DEPARTING CFO TIM HENDRICKSON
* HLS THERAPEUTICS INC: HENDRICKSON WILL REMAIN IN HIS ROLE
UNTIL
JANUARY 26, 2024
Source text for Eikon: ID:nCNWDxBSya
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group